in this issue
World News and Views :: Projects
Wacker Builds Biologics
12:43 PM MDT | April 3, 2009
Wacker Chemie says it will develop its biologics operation at Jena, Germany as part of a strategy to expand the company’s fine chemicals business. The Jena facility specializes in using microbial systems, mainly E-coli, for the production of biologics. Wacker is investing about €15 million ($20 million) to expand the operation including a recently opened new process-development unit for pharmaceutical proteins. The company also will double the size of its Jena GMP production facility for biopharmaceuticals by year-end. Wacker has pulled out of contract...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee